EQUITY RESEARCH MEMO

Johari Medtech

Generated 5/24/2026

Executive Summary

Conviction (model self-assessment)70/100

Johari Medtech, operating as Syrma Johari MedTech Ltd., is an Indian contract development and manufacturing organization (CDMO) specializing in electronic medical devices. Founded in 2020 and headquartered in Mumbai, the company provides end-to-end services including concept design, design-for-manufacturing, PCB assembly, and regulatory support. Its focus areas span pain management, medical aesthetics, diagnostics, critical care, patient monitoring, and surgical devices. With a workforce of 500–1000 employees, Johari Medtech serves as a strategic partner for medtech innovators seeking cost-effective and scalable manufacturing solutions in India. The company is well-positioned to benefit from the growing demand for outsourced medical device manufacturing, particularly in Asia. Its comprehensive service offerings and regulatory expertise enable it to capture value across multiple therapeutic segments. While still private and without disclosed financials, Johari Medtech's established customer base and expanding capabilities suggest strong growth potential. Key catalysts include new contract wins, facility expansions, and entry into regulated markets like the US and Europe.

Upcoming Catalysts (preview)

  • Q4 2026Major contract win with a top-10 medtech OEM60% success
  • Q2 2026Regulatory clearance for new Mumbai manufacturing facility70% success
  • Q3 2026FDA or CE mark certification enabling entry into US/EU markets50% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)